chronic lymphocytic leukemia
Showing NaN - NaN of 108
Chronic Lymphocytic Leukemia Trial in Houston (Ofatumumab)
Active, not recruiting
- Chronic Lymphocytic Leukemia
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Feb 23, 2022
Chronic Lymphocytic Leukemia, Non-Hodgkin Lymphoma Trial in Australia, United States (ABT-199)
Completed
- Chronic Lymphocytic Leukemia
- Non-Hodgkin Lymphoma
-
Tucson, Arizona
- +9 more
Feb 10, 2022
Leukemia, Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Worldwide (ibrutinib, venetoclax, Placebo)
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Lymphoblastic Leukemia in Remission, Acute Myeloid
Active, not recruiting
- Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
- +12 more
- Laboratory Biomarker Analysis
- +2 more
-
Duarte, California
- +2 more
Feb 17, 2022
Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia Trial in Houston (autologous or syngeneic PBTLs and EBV-CTLs)
Active, not recruiting
- Non-Hodgkin Lymphoma
- Chronic Lymphocytic Leukemia
- autologous or syngeneic PBTLs and EBV-CTLs
-
Houston, Texas
- +1 more
Feb 6, 2022
Chronic Lymphocytic Leukemia Trial in Houston (Questionnaire Administration, Ruxolitinib Phosphate)
Active, not recruiting
- Chronic Lymphocytic Leukemia
- Questionnaire Administration
- Ruxolitinib Phosphate
-
Houston, TexasM D Anderson Cancer Center
Feb 2, 2022
Chronic Lymphocytic Leukemia, 17p Deletion, Cancer of the Blood and Bone Marrow Trial in Worldwide (ABT-199 (Main Cohort),
Completed
- Chronic Lymphocytic Leukemia
- +2 more
- ABT-199 (Main Cohort)
- ABT-199 (Safety Expansion Cohort)
-
Tucson, Arizona
- +47 more
Nov 19, 2021
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Worldwide (Zanubrutinib, Ibrutinib)
Active, not recruiting
- Chronic Lymphocytic Leukemia
- Small Lymphocytic Lymphoma
-
Little Rock, Arkansas
- +144 more
Dec 3, 2021
B-cell Non-Hodgkins Lymphoma, Chronic Lymphocytic Leukemia Trial in France, United States (XmAb13676)
Recruiting
- B-cell Non-Hodgkins Lymphoma
- Chronic Lymphocytic Leukemia
- XmAb13676
-
La Jolla, California
- +21 more
Oct 20, 2021
Non-Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia Trial in United States (hLL1-DOX (IMMU-115))
Terminated
- Non-Hodgkin's Lymphoma
- Chronic Lymphocytic Leukemia
- hLL1-DOX (IMMU-115)
-
Newark, Delaware
- +5 more
Oct 6, 2021
Chronic Lymphocytic Leukemia, Recurrent Transformed Chronic Lymphocytic Leukemia, Refractory Transformed Chronic Lymphocytic
Recruiting
- Chronic Lymphocytic Leukemia
- +4 more
- Atezolizumab
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Sep 30, 2021
Chronic Lymphocytic Leukemia, Leukemia Trial in Houston (Fludarabine, Cyclophosphamide, Rituximab)
Completed
- Chronic Lymphocytic Leukemia
- Leukemia
- Fludarabine
- +2 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Aug 11, 2021
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Worldwide (Post-Chlorambucil Therapy Follow-up, Ibrutinib,
Active, not recruiting
- Chronic Lymphocytic Leukemia
- Small Lymphocytic Lymphoma
- Post-Chlorambucil Therapy Follow-up
- +4 more
-
Duarte, California
- +106 more
Aug 6, 2021
Chronic Lymphocytic Leukemia Trial in Houston (Ofatumumab)
Completed
- Chronic Lymphocytic Leukemia
- Ofatumumab
-
Houston, TexasM D Anderson Cancer Center
Jul 22, 2021
Chronic Lymphocytic Leukemia, Peripheral T-cell Lymphoma Trial in United States (20 mg/kg TRU-016 + Rituximab, 10 mg/kg TRU-016
Terminated
- Chronic Lymphocytic Leukemia
- Peripheral T-cell Lymphoma
- 20 mg/kg TRU-016 + Rituximab
- +5 more
-
Augusta, Georgia
- +7 more
May 18, 2021
Indolent Non-Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma Trial in United States (Idelalisib,
Completed
- Indolent Non-Hodgkin's Lymphoma
- +2 more
- Idelalisib
- +8 more
-
Huntsville, Alabama
- +10 more
Feb 22, 2021
Acute Myeloid Leukemia, Chronic Lymphocytic Leukemia Trial in Houston (Educational Intervention, Questionnaire Administration,
Recruiting
- Acute Myeloid Leukemia
- Chronic Lymphocytic Leukemia
- Educational Intervention
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Feb 25, 2021
Double Cord Blood Transplant, Acute Myelogenous Leukemia, Myelodysplastic Syndrome Trial in Houston (TXA127 300 mcg/kg/day,
Terminated
- Double Cord Blood Transplant
- +8 more
- TXA127 300 mcg/kg/day
- TXA127 1000 mcg/kg/day
-
Houston, TexasMD Anderson Cancer Center
Dec 7, 2020
Leukemia, Acute Myeloid Leukemia, Acute Lymphocytic Leukemia Trial in Houston (Fludarabine monophosphate, Busulfan, Stem Cell
Active, not recruiting
- Leukemia
- +9 more
- Fludarabine monophosphate
- +5 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Oct 2, 2020
Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma Trial in United States (Entospletinib,
Terminated
- Chronic Lymphocytic Leukemia
- +3 more
-
La Jolla, California
- +12 more
May 18, 2020
Leukemia, Chronic Lymphocytic Leukemia, Lymphocytic Leukemia Trial in Houston (Lirilumab, Rituximab)
Completed
- Leukemia
- +2 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
May 26, 2020
Connectâ„¢ CLL: The Chronic Lymphocytic Leukemia Disease Registry
Completed
- Chronic Lymphocytic Leukemia
-
Pomona, California
- +164 more
May 8, 2020